David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAT
1176
American Assets Trust
AAT
$1.42B
| $5.57M | 0.01% |
139,541
+99,900
| +252% | +$3.73M |
|
1177
FNB Corp
FNB
$6.54B
| $5.57M | 0.01% |
427,872
+415,212
| +3,280% | +$5.17M |
|
1178
Telephone and Data Systems
TDS
$3.89B
| $5.57M | 0.01% |
184,964
+36,511
| +25% | +$921K |
|
1179
Cintas
CTAS
$81.9B
| $5.56M | 0.01% |
247,764
-73,112
| -23% | -$1.57M |
|
1180
Bankunited
BKU
$3.3B
| $5.55M | 0.01% |
161,033
-313,958
| -66% | -$10.5M |
|
|
LTC
1181
LTC Properties
LTC
$2.19B
| $5.54M | 0.01% |
122,425
+38,210
| +45% | +$1.69M |
|
|
NBIS
1182
Nebius Group N.V.
NBIS
$60.3B
| $5.54M | 0.01% |
361,465
+187,084
| +107% | +$2.56M |
|
1183
PUT
Salesforce
CRM
$168B
| $5.52M | 0.01% |
74,800
-5,200
| -7% | -$358K |
|
1184
Itaú Unibanco
ITUB
$84.4B
| $5.5M | 0.01% |
1,452,339
-1,187,150
| -45% | -$3.62M |
|
1185
PUT
Comcast
CMCSA
$96.2B
| $5.5M | 0.01% |
180,000
-923,800
| -84% | -$26.5M |
|
|
JBTM
1186
JBT Marel
JBTM
$6.12B
| $5.49M | 0.01% |
97,343
-16,896
| -15% | -$822K |
|
|
TXNM
1187
TXNM Energy Inc
TXNM
$5.91B
| $5.49M | 0.01% |
162,748
-87,920
| -35% | -$2.81M |
|
1188
PUT
Cencora
COR
$62.6B
| $5.48M | 0.01% |
63,300
-18,300
| -22% | -$1.63M |
|
1189
Generac Holdings
GNRC
$11.9B
| $5.48M | 0.01% |
147,047
+69,330
| +89% | +$2.23M |
|
1190
Veeco
VECO
$2.91B
| $5.46M | 0.01% |
280,178
-79,914
| -22% | -$1.47M |
|
|
X
1191
CALL
DELISTED
US Steel
X
| $5.46M | 0.01% |
+340,000
| New | +$3.39M |
|
|
TWX
1192
CALL
DELISTED
Time Warner Inc
TWX
| $5.44M | 0.01% |
75,000
+30,000
| +67% | +$2.07M |
|
1193
PUT
Freeport-McMoran
FCX
$115B
| $5.43M | 0.01% |
525,300
-3,069,600
| -85% | -$21.6M |
|
1194
Molson Coors Class B
TAP
$7.83B
| $5.43M | 0.01% |
56,418
+53,450
| +1,801% | +$4.77M |
|
1195
CALL
Perrigo
PRGO
$2.01B
| $5.42M | 0.01% |
42,400
-78,800
| -65% | -$10.8M |
|
|
ISIL
1196
DELISTED
Intersil Corp
ISIL
| $5.42M | 0.01% |
405,629
+285,585
| +238% | +$3.57M |
|
1197
Theravance Biopharma
TBPH
$884M
| $5.42M | 0.01% |
288,070
-122,057
| -30% | -$2M |
|
1198
CoreCivic
CXW
$3.28B
| $5.4M | 0.01% |
168,523
-68,395
| -29% | -$2M |
|
1199
PUT
Altria Group
MO
$114B
| $5.4M | 0.01% |
86,200
-214,600
| -71% | -$13M |
|
|
MSGN
1200
DELISTED
MSG Networks Inc.
MSGN
| $5.39M | 0.01% |
311,913
-830,068
| -73% | -$14.5M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.